The company said in a notice to BSE that it will partner Nevakar LLC for developing and commercialize injected products for US. India Infoline, 2 months ago
Themis Medi up 16% on pact with US co for injectable products - Money Control, 2 months ago
Themis Medicare inks pact with Nevakar for injectable products - Business Standard, 2 months ago
1 images for "Us Injectables Llc"
The Pharmacovigilance Risk Assessment Committee of the European Medicines Agency (EMA) has begun a review of select injectable allergy medications containing methylprednisolone because they may pose risks to those who are allergic to cows' milk, ...Dermatology Online Journal, 1 day ago
SAN JUAN CAPISTRANO, Calif.--( BUSINESS WIRE )--Allegro Ophthalmics, LLC, a biotechnology company focused on the development of novel therapies to treat vitreoretinal diseases, today announced that William J. Link, PhD, has been elected to Allegro's ...Business Wire, 1 week ago
BRIDGEWATER, N.J., Dec. 2, 2016 /PRNewswire/ -- To help processors of meat, poultry, and other foods raise the bar on food safety and productivity in mixer chilling operations, Linde LLC announces new LIXSHOOTER® bottom injectors, which are ...TickerTech.com, 1 day ago
DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Mylan N.V. (MYL) and Lead Plaintiff Deadline: December 12, 2016
/ Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Mylan N.V. ("Mylan" or the "Company") ( NASDAQ: MYL ) and certain of its officers, on behalf of shareholders who purchased Mylan securities ...Nation's Restaurant News, 1 day ago DEADLINE ALERT Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Mylan N.V. (MYL) and Lead Plaintiff Deadline: December 12, 2016 SSUChronicle.com, 1 day ago SHAREHOLDER ALERT - BRONSTEIN, GEWIRTZ & GROSSMAN, LLC REMINDS INVESTORS OF CLASS ACTION AGAINST MYLAN N.V. (MYL) AND LEAD PLAINTIFF DEADLINE : December 12, 2016 4 Traders, 4 days ago MYLAN NV : DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Mylan N.V. (MYL) and Lead Plaintiff Deadline: December 12, 2016 4 Traders, 1 day ago
Crystal Research Associates, LLC Issues Executive Informational Overview on Hemispherx Biopharma, Inc.
Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview® (EIO) on Hemispherx Biopharma, Inc. (NYSE MKT: HEB). The full 60-page report is available on Crystal Research Associates' website at ...Stockwatch, 2 days ago
BRIDGEWATER, N.J., Nov. 30, 2016 /PRNewswire/ -- Akin Malas, head of metals market applications technology for Linde LLC, Americas, detailed advancements in furnace atmosphere circulation technology in a case study presentation to a well-attended ...TickerTech.com, 3 days ago
11/23/16 - Phase 3 Study Results Supporting U.S. FDA and European Commission Approvals of STELARA in the Treatment of Moderately to Severely Active Crohn's Disease Published in The New England Journal of Medicine
Release date- 22112016 - SPRING HOUSE, P.A- Results from three pivotal Janssen Research & Development, LLC (Janssen)-sponsored Phase 3 studies published today in The New England Journal of Medicine show that treatment with STELARA(ustekinumab) ...Pharmacy Choice, 1 week ago Phase 3 Study Results Supporting U.S. FDA and European Commission Approvals of STELARA® in the Treatment of Moderately to Severely Active Crohn's Disease Published in The New England Journal of Medici BioSpace, 2 weeks ago New Phase 3 Monotherapy Study of Sirukumab Versus Humira® and Sirukumab Data in... Freshnews.com, 2 weeks ago 11/17/16 - PHASE 3 STUDY RESULTS SUPPORTING U.S. FDA AND EUROPEAN COMMISSION APPROVALS OF STELARA IN THE TREATMENT OF MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE PUBLISHED IN THE NEW ENGLAND JOURNAL OF MEDICINE Pharmacy Choice, 2 weeks ago
Linde Safety Solution for Heat Treatment Furnaces Monitors Supply of Nitrogen Needed for Safety Purge
BRIDGEWATER, N.J., Nov. 15, 2016 /PRNewswire/ -- Linde LLC helps companies operating by installing a protective-atmosphere safety monitoring system in compliance with the National Fire Protection Association's "Standard for Ovens and Furnaces" (NFPA ...International Business Times, 2 weeks ago
More from: , PR Newswire...and 5 other sources
Johnson & Johnson Innovation And Award U.S. $1.5 Million In Grants For World Without Disease Quickfire Challenge
NEW YORK , Nov. 14, 2016 /PRNewswire/ -- Johnson & Johnson Innovation LLC and Janssen Research & Development, LLC (Janssen) today announced multiple recipients of U.S. $500,000 grants and offers of residency at Johnson & Johnson Innovation | JLABS ...BioSpace, 2 weeks ago Johnson & Johnson Innovation and Janssen Award U.S. $1.5 Million in Grants for World Without Disease QuickFire Challenge WorldNetDaily, 2 weeks ago
More from: , TickerTech.com...and 4 other sources
on your WebpageAdd Widget >Get your members hooked!